PUBLICATIONS · 34780709
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2021 Dec
- First author
- Fischer M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2021 Dec;22(12):1646-1648. doi: 10.1016/S1470-2045(21)00608-2.
- note
- Source null
- related pmid
- 34780708
- relationship
- Comment in
Authors and identifiers
- name
- Fischer M
- type
- Author
- name
- Moreno L
- type
- Author
- name
- Ziegler DS
- type
- Author
- name
- Marshall LV
- type
- Author
- name
- Zwaan CM
- type
- Author
- name
- Irwin MS
- type
- Author
- name
- Casanova M
- type
- Author
- name
- Sabado C
- type
- Author
- name
- Wulff B
- type
- Author
- name
- Stegert M
- type
- Author
- name
- Wang L
- type
- Author
- name
- Hurtado FK
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Fischer M
- type
- Author
- name
- Moreno L
- type
- Author
- name
- Ziegler DS
- type
- Author
- name
- Marshall LV
- type
- Author
- name
- Zwaan CM
- type
- Author
- name
- Irwin MS
- type
- Author
- name
- Casanova M
- type
- Author
- name
- Sabado C
- type
- Author
- name
- Wulff B
- type
- Author
- name
- Stegert M
- type
- Author
- name
- Wang L
- type
- Author
- name
- Hurtado FK
- type
- Author
- bibliography ids
- nci-bib-027b957724a4d78bf19ff2b7
- book metadata
- content sha256
- 6efcb42b7b2ddad869b0d2e6d88d28a473436aec7cb0d898c340451e6ba27702
- document type
- citation
- dois
- 10.1016/S1470-2045(21)00536-2
- electronic publication date
- display
- 2021 Nov 12
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34780709
- immutable id
- pubmed:34780709@6efcb42b7b2ddad869b0d2e6d88d28a473436aec7cb0d898c340451e6ba27702
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 12
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1764-1776
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2021 Dec;22(12):1646-1648. doi: 10.1016/S1470-2045(21)00608-2.
- note
- Source null
- related pmid
- 34780708
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 34780709
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- 006f89c9aa63083d6f70876d76e7267afdc70fbb0c74820438c9ad96e1832785
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2021 Dec
- precision
- month
- year
- 2021
- publication types
- Clinical Trial, Phase I
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.
Preserved source evidence · Not medical advice
Triangle